Greenwich LifeSciences, Inc. (GLSI) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Greenwich LifeSciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Greenwich LifeSciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $4.51 M, a 43.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.51 M +$1.37 M +43.6% Dec 31, 2023 10-K 2024-04-15
Q4 2022 $3.14 M +$1.28 M +68.7% Dec 31, 2022 10-K 2024-04-15
Q4 2021 $1.86 M +$821 K +79% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $1.04 M +$249 K +31.5% Dec 31, 2020 10-K 2022-03-21
Q4 2019 $790 K Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.